The gut microbiome and intestinal barrier are extremely sensitive structures vulnerable to both internal and external factors, including nutrition, lifestyle factors, medications, illness, and trauma. These insults can induce transient or even prolonged states of dysbiosis, a condition characterized by alterations to the composition, diversity, and metabolism of the gut microbiome. The disruption goes both ways, creating a vicious cycle whereby a disturbed microbiome feeds forward to negatively impact immune, metabolic, and disease processes.
Given the influence of the gut microbiome on host health, the sooner the microbiome is restored to its optimal function, the sooner it can facilitate re-establishment of physiological homeostasis. Novel strategies are under active investigation, such as fecal microbiota transplantation and new-generation probiotics designed to potentiate a recovery of microbiota composition.
Acute brain injury is a particularly destabilizing event to the gut microbiome. Studies have revealed a prominent shift toward increased Pseudomonadota and Verrucomicrobiota phyla members. Relative quantities of Bacteroidota, Actinomycetota, and Bacillota have also been demonstrated to be altered. Regardless of whether the injury is traumatic or non-traumatic, the microbiome appears to be similarly affected. While the disturbance seems to resolve in the long term, the temporary changes may delay restoration of cognitive function and brain barrier integrity.
As the composition of the gut microbiome oscillates, so do the metabolites it produces. Microbiota-derived organic acids, short-chain fatty acids, amino acids, carbohydrates, and tryptophan metabolites are variably impacted. In some cases, these alterations elicit a state of immune hyper-vigilance, tissue degradation, and drug resistance. In other scenarios, microbial activity stalls, impairing metabolism of cofactors, vitamins, and nucleotides, diminishing carbohydrate biosynthesis, and compromising DNA replication and repair, cell motility, and membrane transport.
Research suggests a reduction in the butyrate-producing species Bacillota critical for intestinal health and immunomodulation. Meanwhile, Pseudomonadota proliferation exacerbates a pro-inflammatory state. Combined gastrointestinal dysfunction and disrupted microbial composition further contribute to immune system dysregulation, pro-inflammatory cytokine release, and suppressed anti-inflammatory cytokine levels, triggering an infiltration of T cells into the brain. Altered enteric nervous system signaling acts to stall gut motility, and epithelial cell metabolism is hindered. A leaky intestinal barrier subsequently permits efflux of damaging substances from the gut into circulation.
Brain trauma is followed by a stress response characterized by neuro-inflammation, autonomic and enteric nervous system dysregulation, and ensuing gastrointestinal sequelae. As the microbiome responds, a new environment is cultivated in which harmful bacteria crowd out those capable of restoring homeostasis. Collectively, dysbiosis not only underlies impaired gut function and a weakened intestinal lining, but also activates the systemic immune system and disturbs enteric neurotransmission. These secondary effects feed back to intensify gut-brain axis disorder. A cytokine storm creates a vicious cycle of chronic immune activation and metabolic and neural dysfunction capable of causing secondary brain injury. Gut microbiome-targeted strategies aimed at rapidly re-establishing eubiosis are thus a key and ongoing area of investigation in the alleviation of brain trauma pathology.
Occhiali E, Renard D, Molkhou C, et al. Systematic Review with Qualitative Synthesis of Gut Microbiota Alterations after Acute Brain Injury. J Neurotrauma. Published online May 7, 2026. doi:10.1177/08977151261449708
Leave a Reply